Target detail
ABHD16A
abhydrolase domain containing 16A, phospholipase
Data: Live structured evidence (Supabase)
Foundation row from public.targets — full Open Targets / ChEMBL preload remains a future operator job (Phase 8H+).
Display name: abhydrolase domain containing 16A, phospholipase
Aliases: ABHD16A, abhydrolase domain containing 16A, phospholipase
Type / organism: protein_coding · Homo sapiens
Source: opentargets · ENSG00000204427
Index freshness: last_synced_at 2026-05-15T18:35:01.797+00:00 · updated 2026-05-15T18:35:02.262733+00:00
Limitations & build flags
- Read-only structured navigator
- No clinical outcome benefit inferred
- Trial presence does not imply success
- Drug identity may require normalization
- Terminated/withdrawn trials must remain visible
This symbol is listed in public.targets (operator seed or future preload). Connector-backed sections below may still show empty states until ChEMBL / Open Targets / ClinicalTrials.gov mirror rows exist for this marker.
Connectors represented in loaded rows for ABHD16A. Empty groups mean no matching rows — not a claim about biology or clinical use.
- Open TargetsLive when indexed
Disease–target evidence rows when operators run enrich:opentargets (GraphQL from trusted scripts only).
- ChEMBLLive when indexed
Drug–target and related enrichment rows when operators run enrich:chembl (server/CLI only).
Rows from disease_target_evidence for this symbol.
glioblastoma
literature · opentargets
Drug records tied via drug_targets — mechanistic linkage only.
CHEMBL4545967
chembl4545967
CHEMBL5403536
chembl5403536
CHEMBL4483417
chembl4483417
CHEMBL4564841
chembl4564841
CHEMBL4526442
chembl4526442
CHEMBL4536177
chembl4536177
CHEMBL4468340
chembl4468340
CHEMBL4589105
chembl4589105
CHEMBL4525638
chembl4525638
CHEMBL4534626
chembl4534626
CHEMBL5433925
chembl5433925
CHEMBL5425329
chembl5425329
CHEMBL4521943
chembl4521943
CHEMBL4461610
chembl4461610
CHEMBL5560768
chembl5560768
CHEMBL4519648
chembl4519648
CHEMBL5532498
chembl5532498
CHEMBL5395692
chembl5395692
CHEMBL4591378
chembl4591378
PALMOSTATIN B
chembl1673415
CHEMBL1550905
chembl1550905
CHEMBL4593614
chembl4593614
CHEMBL4579113
chembl4579113
CHEMBL4471587
chembl4471587
CHEMBL158897
chembl158897
CHEMBL4583995
chembl4583995
CHEMBL5412295
chembl5412295
CHEMBL4437695
chembl4437695
CHEMBL4585683
chembl4585683
CHEMBL4546288
chembl4546288
CHEMBL4450218
chembl4450218
ORLISTAT
chembl175247
CHEMBL4577250
chembl4577250
disease_drug_evidence rows on linked drugs whose evidence_type suggests approved-elsewhere discussion context.
No matching rows
Import repoDB-compatible disease–drug evidence or add structured rows to surface discussion candidates here.
Mirror rows whose text fields mention this symbol — registry context only.
No matching live evidence found
Populate clinical_trials via the registry enrichment flow; this panel matches the symbol token in titles, conditions, or interventions.
Repurposing signal rows for drugs linked to this target via drug_targets.
No research signals for linked drugs
Run the deterministic signal builder after drug_targets and source rows are present.
Structured rows with negative evidence_direction on disease–drug or signal tables.
No negative-direction rows
When structured evidence includes explicit negative direction fields, they surface here for oncology review.
No ClinicalTrials.gov mirror rows mention this symbol in titles, conditions, or interventions (within the loaded window).
- chembl: 33
- opentargets: 1
Structured evidence rows link this marker to cohort contexts when ingested — interpret as research context only.
Disease contexts
0
Linked drugs
0
Linked in dataset
0
Research signals
0
Doctor-discussion candidate and related tags are descriptive only.
Signals list: Live structured evidence (Supabase)
No matching live evidence found
When repurposing_signal rows reference this marker via linked drugs, summaries appear here.